Market Place
Sourcing Support
Pfizer Europe Emblaveo (aztreonam / avibactam) Receives Approval in Europe
24 Apr 2024 //
EMA
EU Approves Pfizer`s EMBLAVEO For MDR Infections
22 Apr 2024 //
BUSINESSWIRE
Hospira, Inc`s Generic Aztreonam Receives Approval In US
15 Nov 2021 //
FDA
Hospira, Inc’s Generics Aztreonam Receives Approvals In US
10 Nov 2021 //
FDA
The effect of generic market entry on antibiotic prescriptions in the US
18 May 2021 //
NATURE
Allergan Receives FDA (QIDP) Designation & Fast Track Designation For ATM-AVI
11 Nov 2019 //
PR NEWSWIRE
Basilea moves closer to US filing of novel antibiotic
06 Aug 2019 //
PMLIVE
Enforcement Report - Week of May 16, 2018
16 May 2018 //
FDA
Melinta Therapeutics seeks US FDA approval for Baxdela to treat ABSSSI
25 Oct 2016 //
PHARMABIZ
Inspired by $220M in BARDA funding, AstraZeneca steps up antibiotics R&D
18 Sep 2015 //
FIERCE BIOTECH
Allergan Announces FDA Approval of Updated Label for TEFLARO® (ceftaroline fosamil)
02 Sep 2015 //
PR NEWS WIRE
Study finds essential antibiotics are often in short supply in U.S.
24 Apr 2015 //
FIERCE PHARMA MANUFACTURING
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.